tirzepatide weight loss percentage Lower Zepbound dose may help maintain in obesity The percent change in body

These metabolic improvements contribute to better overall cardiovascular health

If eligible, the plan may include medication options, nutrition, physical activity, follow-up care, and insurance documentation support

Zepbound (tirzepatide) is FDA-approved for weight management

Ultimately, your weight loss journey is a personal one, and your Shapely team will be by your side to help you achieve your best results Typically, we find that patients of our weight loss program in Eastvale, California who are taking GLP-1 agonists such as Ozempic and Wegovy will lose 10% of weight by 6 months and 15% within 1 year

(Lowe DA et al., Cell Metabolism , 2022, The takeaway is that the combination can work, but protein intake within the eating window is the variable that determines whether results are genuinely better or simply faster at the cost of muscle mass